Belmedpreparaty starts exporting drugs to Syria and Vietnam, it was learnt from Tatiana Trukhacheva, Deputy Director- General of the company, on 13 October.

The experts from these countries visited the company and highly valued its quality control system. Syria and Vietnam are especially interested in oncology drugs.

“The company is looking to advance to new sales markets. Our products are exported to the EU and South Korea,” said Tatiana Trukhacheva.

In January-September 2009, the company’s export increased by 18.5% as against the same period of 2008. The company drafted about 60 registration dossiers on new medicines in 2009. The dossiers have been sent for certification in the CIS countries.

The enterprise has launched a number of investment projects to upgrade the manufacture of antitumor powders and solutions for injections. The company is certifying the upgraded tablet manufacture for compliance with the GMP international standards.

Belmedpreparaty is one of the largest pharmaceutical enterprises in Belarus and the only producer of blood substitutes, insulin, medicine for oncological diseases, tuberculosis, etc. The factory owns more than 100 trademark certificates and more than 50 patents of different authorities. In May 2009 Belmedpreparaty won the Best Innovative Enterprise nomination of the nationwide Technosphera-2008 contest. The drugs are registered and exported to Russia, Ukraine, Armenia, Uzbekistan and other countries.

www.belta.by